334 related articles for article (PubMed ID: 17245358)
1. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
3. Interaction of endocannabinoid system and cyclooxygenase metabolites with fatty acid amide hydrolase and cyclooxygenase enzyme activities on contractile responses in rat vas deferens tissue.
Vural EH; Ozturk Fincan GS; Okcay Y; Askin CI; Gudul Bacanli M; Vural IM
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4123-4137. PubMed ID: 38032490
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
5. Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.
Baranowska-Kuczko M; MacLean MR; Kozłowska H; Malinowska B
Pharmacol Res; 2012 Sep; 66(3):251-9. PubMed ID: 22627170
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
Lau BK; Drew GM; Mitchell VA; Vaughan CW
Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid signaling in inhibitory autaptic hippocampal neurons.
Straiker A; Mackie K
Neuroscience; 2009 Sep; 163(1):190-201. PubMed ID: 19501632
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR
Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries.
Baranowska-Kuczko M; Kozłowska H; Kozłowski M; Schlicker E; Kloza M; Surażyński A; Grzęda E; Malinowska B
Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):477-86. PubMed ID: 24682422
[TBL] [Abstract][Full Text] [Related]
13. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
Ho WS; Barrett DA; Randall MD
Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
[TBL] [Abstract][Full Text] [Related]
14. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
16. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypertension on vasorelaxation to endocannabinoids in vitro.
Wheal AJ; Randall MD
Eur J Pharmacol; 2009 Jan; 603(1-3):79-85. PubMed ID: 19100733
[TBL] [Abstract][Full Text] [Related]
18. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
Grainger J; Boachie-Ansah G
Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448
[TBL] [Abstract][Full Text] [Related]
19. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
20. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
